
Diabetic foot ulcers are one of the most serious complications of diabetes, affecting approximately 15% of diabetic patients during their lifetime. Without proper treatment, they can lead to infection, gangrene, and amputation. Cuba has developed Heberprot-P®, a groundbreaking medication that has revolutionized diabetic foot ulcer treatment, significantly reducing amputation rates. At La Pradera International Health Center, our multidisciplinary diabetic foot clinic offers comprehensive care including Heberprot-P® therapy, advanced wound care, and limb salvage programs.
Mehr über dieses Behandlungsprogramm erfahren
A diabetic foot ulcer is an open sore or wound that occurs in approximately 15% of patients with diabetes, most commonly on the bottom of the foot. It develops due to a combination of factors including neuropathy (nerve damage), poor circulation, and high blood sugar levels that impair healing.
Neuropathic ulcers — caused by nerve damage, painless
Ischemic ulcers — caused by poor blood flow, painful
Neuro-ischemic ulcers — combination of both
Most common on pressure points of the foot
Can become infected without the patient feeling pain
Preventing diabetic foot ulcers is critical. Regular foot care and early intervention can prevent serious complications. Patients with diabetes should inspect their feet daily and seek immediate medical attention for any wound.
Daily foot inspection for cuts, blisters, or sores
Proper footwear and orthotic inserts
Regular podiatry visits
Blood sugar control (HbA1c management)
Smoking cessation — smoking impairs circulation
Regular vascular and neurological assessment
Prompt treatment of any foot wound
Heberprot-P® is a groundbreaking Cuban medication containing recombinant human epidermal growth factor (EGF), administered by intralesional injection directly into diabetic foot ulcers. Developed by the Center for Genetic Engineering and Biotechnology (CIGB) in Havana, it has been used to treat hundreds of thousands of patients worldwide, dramatically accelerating wound healing and reducing amputation rates.
Contains recombinant human epidermal growth factor (EGF)
Administered by intralesional injection into the wound
Accelerates granulation and wound healing
Significantly reduces amputation rates
Effective on chronic, non-healing ulcers
Used in over 30 countries worldwide
In addition to Heberprot-P®, our diabetic foot clinic offers a range of advanced wound care technologies to support healing and prevent complications.
Laser therapy for wound healing
Ozone therapy for infection control
Electrotherapy to stimulate tissue repair
Advanced wound dressings
Pressure offloading techniques
Surgical debridement when needed
Many diabetic foot ulcers are complicated by poor blood circulation. Our vascular assessment program evaluates blood flow to the lower extremities and provides treatments to improve circulation, which is essential for wound healing.
Non-invasive vascular screening (ankle-brachial index, Doppler)
Carotid and peripheral artery assessment
Cardiovascular risk profiling
Circulation support therapies
Coordination with vascular specialists if needed
Infection is a leading cause of amputation in diabetic foot ulcers. Our clinic follows evidence-based infection management protocols with responsible antibiotic use to treat infections while preventing antibiotic resistance.
Wound culture and sensitivity testing
Targeted antibiotic therapy
Regular wound monitoring and assessment
Surgical intervention for severe infections
Multidisciplinary approach with infectious disease specialists
Our limb salvage program is designed to prevent amputation whenever possible. Through a combination of advanced wound care, Heberprot-P®, vascular support, and surgical intervention when necessary, we help patients preserve their limbs and maintain mobility.
Comprehensive assessment of limb viability
Individualized treatment protocol
Multidisciplinary team approach
Surgical options including revascularization
Post-treatment rehabilitation and podiatry
Our international patient services team assists patients with all travel arrangements to Havana for diabetic foot treatment.
Medical treatment invitation letters
Airport reception and transportation
Accommodation for patient and family
Multilingual coordinators
Halal-certified meals and dietary accommodations
Coordination with your home physician
Senden Sie Ihre Krankenakte und Befunde, und unsere Spezialisten werden Ihren Fall prüfen und einen personalisierten Behandlungsplan empfehlen, der auf Ihre Bedürfnisse zugeschnitten ist.
Beratung AnfragenWhatsAppBehandlung des Diabetischen Fußes
Das Behandlungsprogramm erkunden →
Häufige Fragen internationaler Patienten zur Behandlung auf Kuba.
Heberprot-P® is a Cuban medication containing recombinant human epidermal growth factor (EGF). It is injected directly into diabetic foot ulcers to accelerate healing. It has been used to treat hundreds of thousands of patients and significantly reduces amputation rates.
Wir verwenden Cookies, um Ihre Erfahrung zu verbessern und den Datenverkehr zu analysieren. Mit der Fortsetzung stimmen Sie unserer Verwendung von Cookies zu. Datenschutzerklärung